Inventor · disambiguated record
Vincent A. Florio
Also filed as: FLORIO VINCENT · FLORIO VINCENT A
6 granted patents·17 pending applications·8 citations·filing 2008–2025
75Inventor score
Top patents by PatentIndex Score
23 records- 0184US11827619B2Dichlorophenol HSD17B13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Granted Nov 28, 2023·1 cites·28 claims
- 0283US11234965B2Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditionsOMEROS CORP·Filed 2019·Granted Feb 1, 2022·1 cites·6 claims
- 0378US9119822B2Use of PDE7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2013·Granted Sep 1, 2015·3 cites·37 claims
- 0476US12167999B2Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditionsRAYNER INTRAOCULAR LENSES LTD·Filed 2021·Granted Dec 17, 2024·0 cites·7 claims
- 0576US8637528B2Use of PDE7 inhibitors for the treatment of movement disordersBERGMANN JOHN E·Filed 2009·Granted Jan 28, 2014·3 cites·52 claims
- 0671US12227489B2Dichlorophenol HSD17B13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Granted Feb 18, 2025·0 cites·28 claims
- 0767US2023183239A1Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereofABBVIE INC·Filed 2022·Application pending·0 cites
- 0860US2025376457A1Dichlorophenol hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2025·Application pending·0 cites
- 0959US2008260643A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2008·Application pending·0 cites
- 1057US2018280350A1Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory ConditionsOMEROS CORP·Filed 2017·Application pending·0 cites
- 1155US2020291024A1Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 1255US2019183824A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2018·Application pending·0 cites
- 1351US2016279099A1Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditionsOMEROS CORP·Filed 2015·Application pending·0 cites
- 1450US2024208929A1Hydroxypyridine hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2022·Application pending·0 cites
- 1550US2024208959A1Thiazole/isothiazole hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2022·Application pending·0 cites
- 1649US2023416802A1Specific substrates and products of hsd17b13 as markers of liver disease and biomarkers for liver disease treatmentINIPHARM INC·Filed 2021·Application pending·0 cites
- 1748US2011091388A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2010·Application pending·0 cites
- 1847US2023286923A1Quinazolinone hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2021·Application pending·0 cites
- 1947US2023278978A1Thiophene hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2021·Application pending·0 cites
- 2046US2016015715A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2015·Application pending·0 cites
- 2145US2023150940A1Hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2021·Application pending·0 cites
- 2245US2019282703A1Ectonucleotide pyrophosphatase-phosphodiesterase (enpp) conjugates and uses thereofMAVUPHARMA INC·Filed 2018·Application pending·0 cites
- 2343US2021023234A1Ectonucleotide pyrophosphate-phosphodiesterase (enpp) conjugates and uses thereofABBVIE INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →